{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:16:46Z","timestamp":1792174606419,"version":"4.4.0"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Berberine is a potential therapy for metabolic disorders, yet its effects on visceral adipose tissue (VAT) and liver fat remain uncertain.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate the efficacy and safety of berberine in reducing VAT area and liver fat content in diabetes-free individuals with obesity and metabolic dysfunction\u2013associated steatotic liver disease (MASLD).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this multicenter, double-blind randomized clinical trial, diabetes-free individuals with obesity and MASLD were enrolled at 11 hospitals in China between July 6 and December 29, 2023, with a follow-up duration of 6 months.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomly assigned to receive either oral berberine, 1 g\/d, or a matching placebo.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were relative percentage change in VAT area and absolute change in liver fat content assessed by computed tomography. Other outcomes included changes in parameters of glucose, lipids, and inflammation. Analyses were conducted according to the intention-to-treat principle.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 337 randomized participants (mean [SD] age, 41.8 [10.6] years; 221 [65.6%] male), 169 received berberine and 168 placebo. The mean (SD) medication adherence rates were 90.3% (14.7%) for berberine and 90.7% (17.4%) for placebo. No significant differences were observed between study arms for VAT area (1.4% [97.5% CI, \u22122.4% to 5.2%]) or liver fat content (0.9% [97.5% CI, \u22120.4% to 2.1%). Berberine was associated with larger reductions in low-density lipoprotein cholesterol (\u22127.72 [95% CI, \u221213.13 to \u22121.93] mg\/dL), apolipoprotein B (\u22123.42 [95% CI, \u22126.33 to \u22120.51] mg\/dL) and high-sensitivity C-reactive protein (hs-CRP) (\u22120.072 [95% CI, \u22120.140 to \u22120.004] mg\/dL) vs placebo, but not other secondary outcomes. The incidence of adverse events was similar between study arms. Post hoc analyses suggested consistent patterns of larger reductions in low-density lipoprotein cholesterol, apolipoprotein B, and hs-CRP levels in participants with higher baseline hs-CRP levels.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial of diabetes-free individuals with obesity and MASLD, a 6-month berberine treatment at a daily dose of 1 g had an excellent safety profile but did not reduce VAT area or liver fat content.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05647915<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.54152","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:30:41Z","timestamp":1768581041000},"page":"e2554152","source":"Crossref","is-referenced-by-count":18,"title":["Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD"],"prefix":"10.1001","volume":"9","author":[{"given":"Lubi","family":"Lei","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Lifecycle Health Management Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingshan","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkuo","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Virology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinchu","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Jishuitan Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Guo","sequence":"additional","affiliation":[{"name":"Cardio-Metabolic Medicine Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"BRAVO Collaborative Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojian","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinming","family":"Bai","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibo","family":"Fang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Yu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Yin","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojiong","family":"Jia","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Jin","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Guo","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"He","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengliang","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Hao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Guo","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Guo","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamian","family":"Chen","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefen","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjie","family":"Ji","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangying","family":"Meng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhong","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyin","family":"Feng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"He","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Ren","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiying","family":"Shi","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunjiang","family":"Bai","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihui","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxi","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Jiang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyue","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Hou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Lin","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Zhu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Meng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Pi","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShuangLi","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyun","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Ye","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Mao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyi","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyuan","family":"Liang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtao","family":"Feng","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Chen","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiu","family":"Dou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Ma","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaojuan","family":"Ma","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Pan","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Dang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Yu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibin","family":"Liu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Zhou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailing","family":"He","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Yin","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Cai","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobin","family":"Wang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Jin","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Li","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengnan","family":"Zhu","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Zhou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Hou","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[{"name":"for the BRAVO Collaborative Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"10481","key":"zoi251439r1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021.","volume":"405","author":"Collaborators","year":"2025","journal-title":"Lancet"},{"issue":"9","key":"zoi251439r2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"zoi251439r3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jacc.2021.05.035","article-title":"Management of obesity in cardiovascular practice: JACC Focus Seminar.","volume":"78","author":"Despr\u00e9s","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"zoi251439r4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis.","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"zoi251439r5","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"zoi251439r6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2213-8587(21)00179-0","article-title":"Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial.","volume":"9","author":"Neeland","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"zoi251439r7","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-8587(22)00070-5","article-title":"Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.","volume":"10","author":"Gastaldelli","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"zoi251439r8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial.","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"zoi251439r9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension.","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"zoi251439r10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.","volume":"69","author":"Jensen","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"18","key":"zoi251439r11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss.","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"zoi251439r12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity.","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi251439r13","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"zoi251439r14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.metabol.2008.08.013","article-title":"Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.","volume":"58","author":"Kong","year":"2009","journal-title":"Metabolism"},{"issue":"5","key":"zoi251439r15","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus.","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"issue":"8","key":"zoi251439r16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.metabol.2013.02.007","article-title":"Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.","volume":"62","author":"Chang","year":"2013","journal-title":"Metabolism"},{"issue":"7","key":"zoi251439r17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.7150\/ijbs.54604","article-title":"Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver.","volume":"17","author":"Yu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"zoi251439r18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"zoi251439r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107496","article-title":"Berberine in the treatment of metabolism-related chronic diseases: a drug cloud (dCloud) effect to target multifactorial disorders.","volume":"209","author":"Kong","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"5","key":"zoi251439r20","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","article-title":"Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.","volume":"13","author":"Wei","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"zoi251439r21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","article-title":"The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.","volume":"22","author":"Nie","year":"2024","journal-title":"J Transl Med"},{"issue":"8","key":"zoi251439r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease.","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"zoi251439r23","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1038\/s41467-021-25701-5","article-title":"A phase 2, proof of concept, randomised controlled trial of berberine ursodeoxycholate in patients with presumed non-alcoholic steatohepatitis and type 2 diabetes.","volume":"12","author":"Harrison","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"zoi251439r24","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults.","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"issue":"8","key":"zoi251439r25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","article-title":"International physical activity questionnaire: 12-country reliability and validity.","volume":"35","author":"Craig","year":"2003","journal-title":"Med Sci Sports Exerc"},{"key":"zoi251439r26","first-page":"S41","article-title":"Expert panel report: guidelines (2013) for the management of overweight and obesity in adults.","volume":"22","author":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"zoi251439r27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","article-title":"American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD).","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"issue":"02","key":"zoi251439r28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CD9.0000000000000087","article-title":"Efficacy and safety profile of berberine treatment in improving risk factors for cardiovascular disease: a systematic review and meta-analysis of randomized, double-blind trials.","volume":"03","author":"Lei","year":"2023","journal-title":"Cardiol Discov"},{"issue":"3","key":"zoi251439r29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cen.12294","article-title":"The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment.","volume":"80","author":"An","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"zoi251439r30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.fertnstert.2016.05.022","article-title":"Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome.","volume":"106","author":"Wu","year":"2016","journal-title":"Fertil Steril"},{"issue":"11","key":"zoi251439r31","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCULATIONAHA.117.030501","article-title":"Effect of distinct lifestyle interventions on mobilization of fat storage pools: CENTRAL magnetic resonance imaging randomized controlled trial.","volume":"137","author":"Gepner","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"zoi251439r32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1148\/radiol.2019190467","article-title":"Liver fat content measurement with quantitative CT validated against MRI proton density fat fraction: a prospective study of 400 healthy volunteers.","volume":"294","author":"Guo","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"zoi251439r33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1","key":"zoi251439r34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection: comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"zoi251439r35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"zoi251439r36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.","volume":"59","author":"Zhang","year":"2010","journal-title":"Metabolism"},{"issue":"7","key":"zoi251439r37","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jc.2007-2404","article-title":"Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.","volume":"93","author":"Zhang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi251439r38","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10787-022-00976-2","article-title":"The effects of berberine on inflammatory markers in Chinese patients with metabolic syndrome and related disorders: a meta-analysis of randomized controlled trials.","volume":"30","author":"Lu","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"4","key":"zoi251439r39","doi-asserted-by":"publisher","first-page":"E812","DOI":"10.1152\/ajpendo.90710.2008","article-title":"Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.","volume":"296","author":"Kim","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"zoi251439r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link.","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res"},{"issue":"1","key":"zoi251439r41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","article-title":"Apolipoprotein B: bridging the gap between evidence and clinical practice.","volume":"150","author":"De Oliveira-Gomes","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"zoi251439r42","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target.","volume":"11","author":"Behbodikhah","year":"2021","journal-title":"Metabolites"},{"key":"zoi251439r43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of Cardiology.","author":"Mensah","journal-title":"J Am Coll Cardiol"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844037\/lei_2026_oi_251439_1767982491.72557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:30:42Z","timestamp":1768581042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844037"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.54152","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}